Excessive release or administration of beta-mimetic catecholamines may induce cardiomegaly, necrotic lesions and accumulation of connective tissue in the heart of adult homoiotherms. It was examined here whether similar changes can also be observed at different stages of evolution of the cardiovascular system, i.e. in poikilotherms and in homoiotherms during embryonic life. Sensitivity of the poikilothermic hearts (carp, frog, turtle) to isoproterenol (IPRO) was significantly lower than in the homoiotherms. Necrotic lesions, if present, were localized in the inner spongious musculature which has no vascular supply but which exhibits higher activities of enzymes connected with aerobic oxidation. Moreover, the IPRO-induced decrease of the phospholipid content was also significantly more expressed in the spongious layer. IPRO treatment did not influence the total weight of the fish heart but the proportion of the outer compact layer was significantly higher. These changes were accompanied by an increase of collagen, higher water content and an increase of isomyosin with a lower ATPase activity. The response of the poikilothermic heart to IPRO-induced overload thus differs significantly from that in the homoiotherms. The administration of IPRO during embryonic life of homoiotherms (chick) induces serious cardiovascular disturbances, including cardiomegaly and cellular oedema. Necroses of myofibrils, characteristic of IPRO-induced lesions of adults, were, however, rather exceptional. IPRO did not elevate the concentration of 85Sr (as a calcium homologue) in the immature myocardium; it seems, therefore, that IPRO-induced changes of the embryonic heart are not necessarily due to an intracellular calcium overload. It may be concluded that the character of catecholamine-induced cardiomyopathy is not uniform and depends strictly on the stage of cardiac development.

Institute of Physiology Academy of Sciences of the Czech Republic Prague

Zobrazit více v PubMed

Physiol Bohemoslov. 1980;29(4):323-31 PubMed

Rev Can Biol. 1959 Apr;18(1):83-94 PubMed

Am Heart J. 1969 Jan;77(1):72-80 PubMed

Teratology. 1975 Aug;12(1):33-45 PubMed

Physiol Bohemoslov. 1965;14(5):456-9 PubMed

Ann N Y Acad Sci. 1969 Jan 31;156(1):294-308 PubMed

Am J Obstet Gynecol. 1983 Dec 1;147(7):752-9 PubMed

Physiol Bohemoslov. 1971;20(6):541-7 PubMed

Ann N Y Acad Sci. 1969 Jan 31;156(1):445-68 PubMed

Acta Pathol Microbiol Scand A. 1977 Mar;85A(2):251-62 PubMed

Am J Pathol. 1967 Jan;50(1):27-37 PubMed

Clin Perinatol. 1987 Dec;14(4):931-49 PubMed

Med Serv J Can. 1962 Jul-Aug;18:506-12 PubMed

Comp Biochem Physiol B. 1982;71(1):71-5 PubMed

Comp Biochem Physiol C. 1988;90(1):257-61 PubMed

J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):983-8 PubMed

Physiol Bohemoslov. 1987;36(4):301-11 PubMed

Circ Res. 1985 Oct;57(4):532-7 PubMed

Biochem Pharmacol. 1975 May 1;24(9):999-1002 PubMed

Clin Perinatol. 1987 Dec;14(4):757-82 PubMed

AMA Arch Pathol. 1959 Apr;67(4):443-55 PubMed

Physiol Bohemoslov. 1970;19(1):1-7 PubMed

Physiol Bohemoslov. 1988;37(4):351-3 PubMed

Physiol Bohemoslov. 1985;34(4):381-4 PubMed

Am Heart J. 1968 Nov;76(5):645-9 PubMed

Toxicol Appl Pharmacol. 1965 Jan;7:1-8 PubMed

J Mol Cell Cardiol. 1985 Apr;17(4):291-306 PubMed

Pflugers Arch. 1973;343(1):65-77 PubMed

Basic Res Cardiol. 1988 Jan-Feb;83(1):2-9 PubMed

J Mol Cell Cardiol. 1976 Jul;8(7):533-44 PubMed

Can J Physiol Pharmacol. 1992 Jul;70(7):959-62 PubMed

Cardiovasc Res. 1992 Sep;26(9):845-50 PubMed